Microsure, founded in 2016 and headquartered in The Netherlands, stands out in the Health Care and Medical Devices industries with its pioneering product: robot-assisted microsurgery. The company addresses the intricate challenges faced by supermicrosurgeons, who require precision at sub-millimeter levels, by continuously enhancing their high precision microsurgical robot.
The flagship product, MUSA-2, is celebrated as the first CE certified microsurgical robot, praised for features like scaled movements and tremor filtration. This innovation has been validated through various clinical studies and invaluable feedback has shaped the development of its successor, MUSA-3.
Backed by a robust €38.00M Series B investment on September 19, 2023, Microsystems secured funding from prominent investors, including BOM Brabant Ventures, European Innovation Council, Invest-NL, Kineo Finance, Innovation Industries, Eindhoven University of Technology, Ten Cate Investeringsmaatschappij, and VENTURING TECH. This funding solidifies Microsure's path towards revolutionizing the niche field of microsurgery, ensuring no patient is left without needed treatment.